Familial hypercholesterolemia in 2021

Training Video • Abbott Rapid Diagnostics International

About the CPD course

This on-demand video webcast features Dr Mary McGowan and patient advocate Lisa Khalafi describing the impact of familial hypercholesterolemia (FH) and value of implementing universal paediatric lipid screening. FH is a common genetic disorder leading to elevated low density lipoprotein cholesterol (LDL-C) from birth. Globally out of 220 children; approximately 1 child has FH; and therefore an increased risk of early cardiovascular disease; or even early death. One in ten premature myocardial infarctions is caused by FH. Yet 90% of the 1.3 million Americans with FH are unaware of their condition; leading to premature atherosclerotic cardiovascular disease.

CPD Provider

Abbott Rapid Diagnostics International

View Profile

Send an enquiry

Full Name*

Email Address*

Contact Number*

Industry*

Your Enquiry*

By submitting this form, you consent to CPD sending you email regarding your application.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Abbott Rapid Diagnostics International

Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 109,000 colleagues serve people in more than 160 countries.